SCHEMBL20118622

SCHEMBL20118622

OCOCCN1CCOCC1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.54
ALDH1A1 P00352 2/20 0.54
KEAP1 Q14145 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
TSHR P16473 1/20 0.47
POLB P06746 2/20 0.44
GAA P10253 1/20 0.44
HPGD P15428 1/20 0.44
DUSP3 P51452 1/20 0.44
GLA P06280 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
CYP1A2 P05177 1/20 0.43
CHRM2 P08172 1/20 0.43
CHRM1 P11229 1/20 0.43
HTR2A P28223 1/20 0.43
MAPK1 P28482 1/20 0.43
SCN1A P35498 1/20 0.43
HTR2B P41595 1/20 0.43
KCNH2 Q12809 1/20 0.43
SCN2A Q99250 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL111438 0.86 TSHR (0.58) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL503668 0.85 KDM4E (0.57) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL7106263 0.84 TSHR (0.61) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL22840863 0.83 KDM4E (0.55) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL525957 0.83 KDM4E (0.55) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL4376068 0.82 ALDH1A1 (0.53) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL12371268 0.79 HRH3 (0.46) KDM4EALDH1A1SMN1; SMN2POLBCYP1A2
SCHEMBL8362022 0.78 TSHR (0.51) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL664660 0.78 SMN1; SMN2 (0.48) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR
SCHEMBL474810 0.78 ALDH1A1 (0.51) KDM4EALDH1A1KEAP1SMN1; SMN2TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018081513-A1 PRODRUGS OF KALLIKREIN INHIBITORS BIOCRYST PHARMACEUTICALS, INC. (US) 2018-05-03 WO disclosed